STOCK TITAN
  1. Home
  2. News
  3. 2021-02-28

Stock Market News 2021-02-28

12 news published.

2021-02-27 2021-03-01
IMPACT
SENTIMENT
02/28/2021 09:00 PM
LOGI : Nasdaq LOGN : NYSE
Logitech Increases Fiscal Year 2021 Outlook, Raises Long-Term Financial Model
earnings
IMPACT
SENTIMENT
02/28/2021 08:30 PM
APXT : Nasdaq
AvePoint Launches EduTech To Improve Higher Education Technology
IMPACT
SENTIMENT
02/28/2021 07:00 PM
IVBIY : OTC
Innovent Announces First Patient Outside China Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody
clinical trial
IMPACT
SENTIMENT
02/28/2021 06:00 PM
HSSHF : OTC
Digihost Announces Purchase of Shares by CEO, Michel Amar, for $3.344 Million
IMPACT
SENTIMENT
02/28/2021 06:00 PM
LILA : Nasdaq LILAK : Nasdaq LILAB : NYSE
Liberty Latin America Reports Fiscal 2020 Results
earnings
IMPACT
SENTIMENT
02/28/2021 04:39 PM
JNJ : NYSE
Johnson & Johnson Announces U.S. CDC Advisory Committee Recommends First Single-Shot COVID-19 Vaccine for Adults 18 and Older in U.S.
covid-19
IMPACT
SENTIMENT
02/28/2021 04:00 PM
ECOR : Nasdaq
electroCore Inc. Announces Exclusive Distribution Agreement with Medistar Following Regulatory Approval in Australia
low float
IMPACT
SENTIMENT
02/28/2021 03:59 PM
GNW : NYSE
Genworth Financial Announces Sale of Its Interest in Genworth Mortgage Insurance Australia Limited
IMPACT
SENTIMENT
02/28/2021 01:26 PM
JUSHF : OTC
Jushi Holdings Inc. Issues Statement on the Commonwealth of Virginia Legalizing Cannabis for Adult Use
IMPACT
SENTIMENT
02/28/2021 11:01 AM
DANOY : OTC
Danone: Portfolio review: Conversion of Danone’s 9.8% indirect stake in Chinese partner Mengniu into a direct holding as a first step to disposal
IMPACT
SENTIMENT
02/28/2021 10:40 AM
MINE : OTC
Minerco Introduces Sean Kingston as the Company’s Newest Ambassador
IMPACT
SENTIMENT
02/28/2021 08:00 AM
BBIO : Nasdaq
BridgeBio Pharma and Affiliate Origin Biosciences Announce FDA Approval of NULIBRY™ (fosdenopterin), the First and Only Approved Therapy to Reduce the Risk of Mortality in Patients with MoCD Type A
fda approval
2021-02-27 2021-03-01